In summary, SIK1-3 regulates diverse aspects of bone and cartilage formation and function (FIGURE 10), and thus SIK inhibitors provide exciting new avenues for therapies in osteoporosis and osteoarthritis. This evidence concerns the gene SIK1 and osteoporosis.